These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4032097)

  • 1. Continuous subcutaneous insulin infusion (CSII).
    Wilson DP; Endres RK
    J Okla State Med Assoc; 1985 Jul; 78(7):211-4. PubMed ID: 4032097
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous subcutaneous insulin infusion (CSII) in children with type 1 diabetes.
    Tamborlane WV; Sikes KA; Steffen AT; Weinzimer SA
    Diabetes Res Clin Pract; 2006 Dec; 74 Suppl 2():S112-5. PubMed ID: 17182301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
    Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Continuous subcutaneous insulin infusion in children (CSII)].
    van den Brande JL
    Tijdschr Kindergeneeskd; 1983 Dec; 51(6):227-9. PubMed ID: 6670096
    [No Abstract]   [Full Text] [Related]  

  • 6. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
    Buysschaert M; Lejeune M; Lambert AE
    Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Present role of continuous subcutaneous insulin infusion (CSII) by insulin pump in the treatment of diabetes mellitus].
    Pfützner A; Berger S; Spinas G
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1854-61. PubMed ID: 11132530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous subcutaneous insulin infusion in neonatal diabetes mellitus.
    Wintergerst KA; Hargadon S; Hsiang HY
    Pediatr Diabetes; 2004 Dec; 5(4):202-6. PubMed ID: 15601363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and efficacy of long-term treatment by continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes.
    Van Ballegooie E; Reitsma WD; Sluiter WJ; Doorenbos H
    Neth J Med; 1984; 27(5):185-92. PubMed ID: 6427640
    [No Abstract]   [Full Text] [Related]  

  • 10. [Problems with indications for continuous subcutaneous insulin infusion in 2 juvenile patients with diabetes mellitus].
    Bruining GJ; Van Ballegooie E
    Tijdschr Kindergeneeskd; 1983 Dec; 51(6):223-7. PubMed ID: 6670095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of distinct baseline insulin infusion patterns in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion therapy.
    Holterhus PM; Odendahl R; Oesingmann S; Lepler R; Wagner V; Hiort O; Holl R; ;
    Diabetes Care; 2007 Mar; 30(3):568-73. PubMed ID: 17327322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
    Weintrob N; Shalitin S; Phillip M
    Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy.
    Bruttomesso D; Costa S; Baritussio A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):99-111. PubMed ID: 19172576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus.
    Opipari-Arrigan L; Fredericks EM; Burkhart N; Dale L; Hodge M; Foster C
    Pediatr Diabetes; 2007 Dec; 8(6):377-83. PubMed ID: 18036064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous subcutaneous insulin infusion.
    American Diabetes Association
    Diabetes Care; 2000 Jan; 23 Suppl 1():S90. PubMed ID: 12017692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
    Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
    Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous subcutaneous insulin infusion brings about normal blood sugar in type I diabetes mellitus despite relaxing of diet instructions].
    Sonnenberg GE; Chantelau E; Altenähr H; Berger M; Berchtold P
    Schweiz Med Wochenschr; 1982 Jan; 112(3):83-5. PubMed ID: 7036337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.